The potential of geraniol to reduce cytotoxic and genotoxic effects of MNNG in plant and human lymphocyte test-systems
Autor: | Gabriele Jovtchev, Svetla Gateva, Anna Dobreva, Milka Mileva, Almira Georgieva, Alexander Stankov |
---|---|
Rok vydání: | 2019 |
Předmět: |
0106 biological sciences
Antioxidant medicine.medical_treatment Plant Science Ascorbic acid medicine.disease_cause 01 natural sciences 0104 chemical sciences 010404 medicinal & biomolecular chemistry chemistry.chemical_compound Clastogen Biochemistry chemistry Micronucleus test medicine Butylated hydroxytoluene Cytotoxicity Genotoxicity Geraniol 010606 plant biology & botany |
Zdroj: | South African Journal of Botany. 123:170-179 |
ISSN: | 0254-6299 |
Popis: | Geraniol is a common component of essential oils of various plant species and is widely used in cosmetics, perfumery and household products. In the present study, we investigated the cytotoxic, genotoxic and antioxidant activities of different concentrations of the monoterpenoid geraniol and its anti-cytotoxic and anti-genotoxic potential against the genotoxin N-methyl-N′-nitro-N-nitrosoguanidine (MNNG) in higher plant and human lymphocyte test-systems frequently used in genotoxicity studies. The cytogenetic analysis did not show any inhibition of cell viability for geraniol at concentrations 10–100 μg/ml in barley cells. Only low cytotoxicity was observed in human lymphocytes depending on the concentration. No high clastogenicity for human lymphocytes and low enhancement of the frequencies both of chromosome aberrations and micronuclei were detected in barley. Geraniol showed a good radical-scavenging capacity similar to that of butylated hydroxytoluene (BHT), ascorbic acid and α- tocopherol. Geraniol applied at low nontoxic concentrations possessed a clearly expressed genoprotective potential and could inhibit the cytotoxic/genotoxic effects of MNNG reducing both the frequency of chromosome aberrations and micronuclei induced by the genotoxin. The anti-cytotoxic/anti-genotoxic effects were independent of the experimental schemes of treatment and the test-systems. The obtained results will be useful for further investigations concerning the pharmaceutical and medical application of the monoterpenoid geraniol. |
Databáze: | OpenAIRE |
Externí odkaz: |